Wells Fargo & Company »

Cidara Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 13k 95.76
2025-06-30 $526k 11k 48.71

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Point72 Asset Management
BVF
Vivo Capital
Vanguard Group
BlackRock
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
Morgan Stanley
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics